China Pharma Holdings Ratios (2010-2025) | CPHI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)	11.56%	2.94%	-14.98%	10.45%	-10.56%	-14.22%	-7.01%	1.46%	9.08%	-13.36%	-12.93%	-3.68%	-21.17%	-109.78%	-47.23%	-14.16%	-11.97%	-8.48%	-7.89%	12.30%
EBT Margin (Quarter)	-32.54%	-34.14%	-41.78%	-33.94%	-64.18%	-55.07%	-40.22%	-43.28%	-24.28%	-54.02%	-43.12%	-57.32%	-69.78%	-155.48%	-101.61%	-107.98%	-69.13%	-51.51%	-86.15%	-99.68%
EBIT Margin (Quarter)	-29.53%	-31.17%	-38.53%	47.14%	-56.84%	-48.33%	-35.03%	48.14%	-20.28%	-41.56%	-39.57%	37.10%	-66.87%	-150.44%	-98.65%	-105.47%	-66.76%	-63.57%	-83.06%	-97.90%
EBITDA Margin (Quarter)	-35.56%	-26.55%	-43.68%	-28.97%	-60.96%	-93.94%	-70.69%	-37.00%	-13.81%	-101.72%	-39.16%	-51.46%	-71.36%	-160.40%	-89.10%	-125.87%	-68.47%	-49.53%	-78.57%	-85.18%
Operating Margin (Quarter)	-29.53%	-31.17%	-38.53%	47.14%	-56.84%	-48.33%	-35.03%	48.14%	-20.28%	-41.56%	-39.57%	37.10%	-66.87%	-150.44%	-98.65%	-105.47%	-66.76%	-63.57%	-83.06%	-97.90%
Net Margin (Quarter)	-32.54%	-34.14%	-41.78%	-33.94%	-64.18%	-55.07%	-40.22%	-43.28%	-24.28%	-54.02%	-43.12%	-57.32%	-69.78%	-155.48%	-101.61%	-107.98%	-69.13%	-51.51%	-86.15%	-99.68%
FCF Margin (Quarter)	-11.74%	27.99%	-43.81%	-7.10%	-54.91%	-31.56%	-1.70%	20.95%	-72.04%	-19.30%	52.11%	-1.25%	-42.72%	-7.86%	-3.43%	24.62%	-10.41%	28.60%	-31.42%	5.98%
Efficiency
Inventory Average (Quarter)	3.68M	3.32M	3.03M	3.01M	3.43M	3.72M	3.21M	2.92M	3.35M	3.84M	3.84M	3.75M	3.71M	3.25M	2.66M	2.67M	2.41M	2.33M	2.16M	2.21M
Assets Average (Quarter)	20.48M	19.90M	19.06M	20.42M	21.85M	19.48M	17.06M	16.99M	17.57M	16.53M	15.53M	15.91M	16.33M	15.23M	13.86M	14.18M	14.55M	13.99M	14.79M	23.40M
Equity Average (Quarter)	7.59M	6.85M	6.69M	6.44M	5.68M	4.68M	3.43M	3.56M	4.48M	4.51M	5.23M	6.78M	7.87M	7.85M	6.97M	7.14M	7.36M	6.72M	7.39M	15.53M
Invested Capital (Quarter)	9.19M	9.05M	7.65M	10.35M	9.64M	7.26M	5.89M	4.73M	7.65M	7.19M	7.13M	8.49M	9.32M	8.43M	7.57M	8.89M	7.91M	7.87M	10.27M	24.72M
Asset Utilization Ratio (Quarter)	0.56	0.51	0.51	0.47	0.41	0.42	0.47	0.48	0.48	0.48	0.50	0.44	0.39	0.41	0.40	0.32	0.30	0.31	0.27	0.18
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-205.69	-10.40	-225.10	5.56	-60.15	-137.35	-6.62	-5.75	-5.00	-3.31	-102.79	-3.16	-133.61	-203.08	-158.59	-175.84	-111.78	-96.20	-92.40	-174.47
Debt to Equity (Quarter)	0.40	0.44	0.75	0.72	0.81	0.80	1.62	0.57	0.64	0.65	0.39	0.33	0.29	0.33	0.38	0.33	0.33	0.42	0.24	0.09
Debt Ratio (Quarter)	0.14	0.14	0.28	0.19	0.20	0.18	0.28	0.14	0.17	0.18	0.16	0.15	0.15	0.17	0.18	0.17	0.16	0.20	0.12	0.06
Equity Ratio (Quarter)	0.36	0.33	0.38	0.27	0.25	0.22	0.17	0.24	0.27	0.28	0.40	0.45	0.51	0.52	0.48	0.52	0.49	0.47	0.53	0.73
Times Interest Earned (Quarter)	-205.69	-10.40	-225.10	5.56	-60.15	-137.35	-6.62	-5.75	-5.00	-3.31	-102.79	-3.16	-133.61	-203.08	-158.59	-175.84	-111.78	-96.20	-92.40	-174.47
Dividends & Payouts
FCF Payout Ratio (Quarter)
Valuation
Enterprise Value (Quarter)	-0.50M	-1.80M	-0.46M	-4.86M	-3.71M	-2.24M	-2.09M	-2.03M	-1.17M	-0.90M	-1.37M	-1.42M	-0.84M	-0.74M	-0.72M	-0.63M	-0.41M	-0.63M	-0.30M	-0.35M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	0.00%	0.00%	0.00%	-0.01%	0.00%	-0.01%	-0.01%	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%
Return on Capital Employed (Quarter)	-8.61%	-21.32%	-16.86%	-8.58%	-8.92%	-9.82%	-22.97%	-22.89%	-8.13%	-2.28%	-1.90%	-8.47%	-12.15%	-21.15%	-28.51%	-50.10%	-46.99%	-42.24%	-39.63%	-20.24%
Return on Invested Capital (Quarter)
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%

Research Tools

China Pharma Holdings Ratios (2010-2025) | CPHI

Create an account

Sign In

Reset Password